Skip to main content

Advertisement

Log in

The first report of Apiotrichum mycotoxinivorans isolation from human cerebrospinal fluid

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Fungal infections due to Apiotrichum mycotoxinivorans are clinically rare. Here, we report a case of invasive blood and cerebrospinal fluid infection by Apiotrichum mycotoxinivorans in a girl with B-cell acute lymphoblastic leukemia. This is the first report of the isolation of Apiotrichum mycotoxinivorans from human cerebrospinal fluid. MRI features of meningitis caused by this fungus are presented. Three small isoquinoline alkaloids inhibited the growth of this rare fungus in vitro, providing a starting point for the application of natural products to treat this highly fatal fungal infection. Our case presentation confirms Apiotrichum mycotoxinivorans as a potential emerging pathogen in patients with hematological malignancy undergoing chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. James SA, Bond CJ, Stanley R, Ravella SR, Peter G, Dlauchy D et al (2016) Apiotrichum terrigenum sp. nov., a soil-associated yeast found in both the UK and mainland Europe. Int J Syst Evol Microbiol 66(12):5046–5050. https://doi.org/10.1099/ijsem.0.001467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Peng L, Jiang YQ, Jiang GM, Ou JY, Zeng LT, Zhang HH et al (2019) Molecular identification and biological characteristic analysis of an Apiotrichum mycotoxinivorans (formerly Trichosporon mycotoxinivorans) strain isolated from sputum specimens of a pediatric patient with pneumonia. J Mycol Med 29(2):120–126. https://doi.org/10.1016/j.mycmed.2019.01.010

    Article  CAS  PubMed  Google Scholar 

  3. Hickey PW, Sutton DA, Fothergill AW, Rinaldi MG, Wickes BL, Schmidt HJ et al (2009) Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis. J Clin Microbiol 47(10):3091–3097. https://doi.org/10.1128/JCM.00460-09

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hirschi S, Letscher-Bru V, Pottecher J, Lannes B, Jeung MY, Degot T et al (2012) Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic fibrosis patient. J Clin Microbiol 50(12):4168–4170. https://doi.org/10.1128/JCM.01928-12

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kroner C, Kappler M, Grimmelt AC, Laniado G, Wurstl B, Griese M (2013) The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients - clinical analysis of Trichosporon positive patients in a Munich cohort. BMC Pulm Med 13:61. https://doi.org/10.1186/1471-2466-13-61

    Article  PubMed  PubMed Central  Google Scholar 

  6. Goldenberger D, Hinic V, Prince SS, Tamm M, Balestra AM, Hohler D et al (2016) A case report of a cystic fibrosis patient with repeated isolation of Trichosporon mycotoxinivorans identified by a novel short-extraction method. BMC Infect Dis 16(1):601. https://doi.org/10.1186/s12879-016-1910-7

    Article  PubMed  PubMed Central  Google Scholar 

  7. Almeida JN Jr, Francisco EC, Barberino M, Silva LF, Brandao OM, Colombo AL et al (2017) Emergence of Trichosporon mycotoxinivorans (Apiotrichum mycotoxinivorans) invasive infections in Latin America. Mem Inst Oswaldo Cruz 112(10):719–722. https://doi.org/10.1590/0074-02760170011

    Article  PubMed  PubMed Central  Google Scholar 

  8. Dabas Y, Xess I, Kale P (2017) Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen. Med Mycol 55(5):518–527. https://doi.org/10.1093/mmy/myw100

    Article  PubMed  Google Scholar 

  9. Sadamatsu H, Takahashi K, Tashiro H, Ogusu S, Haraguchi T, Nakashima C et al (2020) A rare case of Trichosporon mycotoxinivorans and Cryptococcus neoformans co-infection in lung. J Infect Chemother 26(8):838–842. https://doi.org/10.1016/j.jiac.2020.03.002

    Article  CAS  PubMed  Google Scholar 

  10. Pang Y, Hu D, Dang Y, Huang S, Qin L, Li M (2022) Bronchial artery-pulmonary artery shunt by Apiotrichum mycotoxinivorans infection in a recurrent hemoptysis case. Infect Drug Resist 15:4611–4615. https://doi.org/10.2147/IDR.S373615

    Article  PubMed  PubMed Central  Google Scholar 

  11. Rex JH, Alexander BD, Andes D, Arthington-Skaggs B, Brown SD, Chaturvedi V et al (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 3rd edn. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA

  12. Abraham J, Chauhan N, Ray S (2022) Virtual screening of alkaloid and terpenoid inhibitors of SMT expressed in Naegleria sp. Molecules 27(17). https://doi.org/10.3390/molecules27175727

  13. Del Poeta M, Chen SF, Von Hoff D, Dykstra CC, Wani MC, Manikumar G et al (1999) Comparison of in vitro activities of camptothecin and nitidine derivatives against fungal and cancer cells. Antimicrob Agents Chemother 43(12):2862–2868. https://doi.org/10.1128/AAC.43.12.2862

    Article  PubMed  PubMed Central  Google Scholar 

  14. Qian W, Yang M, Li X, Sun Z, Li Y, Wang X et al (2020) Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro. Colloids Surf B Biointerfaces 191:111003. https://doi.org/10.1016/j.colsurfb.2020.111003

    Article  CAS  PubMed  Google Scholar 

  15. Wickes BL, Wiederhold NP (2018) Molecular diagnostics in medical mycology. Nat Commun 9(1):5135. https://doi.org/10.1038/s41467-018-07556-5

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zhang SX (2013) Enhancing molecular approaches for diagnosis of fungal infections. Future Microbiol 8(12):1599–1611. https://doi.org/10.2217/fmb.13.120

    Article  CAS  PubMed  Google Scholar 

  17. Liu B, Totten M, Nematollahi S, Datta K, Memon W, Marimuthu S et al (2020) Development and evaluation of a fully automated molecular assay targeting the mitochondrial small subunit rRNA gene for the detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid specimens. J Mol Diagn 22(12):1482–1493. https://doi.org/10.1016/j.jmoldx.2020.10.003

    Article  CAS  PubMed  Google Scholar 

  18. Yao H, Liu J, Xu S, Zhu Z, Xu J (2017) The structural modification of natural products for novel drug discovery. Expert Opin Drug Discovery 12(2):121–140. https://doi.org/10.1080/17460441.2016.1272757

    Article  CAS  Google Scholar 

  19. Xiong B, Wang Y, Chen Y, Xing S, Liao Q, Chen Y et al (2021) Strategies for structural modification of small molecules to improve blood-brain barrier penetration: a recent perspective. J Med Chem 64(18):13152–13173. https://doi.org/10.1021/acs.jmedchem.1c00910

    Article  CAS  PubMed  Google Scholar 

Download references

Availability of data and material

The datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.

Funding

This work was supported by the Science and Technology Department of National Administration of Traditional Chinese Medicine and Health Commission of Shandong Province jointly established the traditional Chinese medicine science and technology project (Grant no. GZY-KJS-SD-2023-065), Research fund of China Maternal and Child Health Research Association (Grant no. 2023CAMCHS003A11), Shandong Provincial Natural Science Foundation (Grant no. ZR2020QH365), the hospital level project of Shandong Province Maternal and Child Health Hospital (Grant no. 2021sf004), and Shandong Provincial Clinical Medical Research Center for Children’s Health and Diseases—multidisciplinary collaboration to carry out clinical promotion and research on the precision diagnosis and treatment of children with infectious diseases (Grant no. RC006).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shifu Wang.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Disclaimer

The funding organizations provided funds for the purchase of laboratory supplies for our study but had no role in the design of the study and the collection, analysis, and interpretation of the data.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

ESM 1

(PDF 811 kb)

ESM 2

(DOCX 16 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, X., Wang, D., Hao, M. et al. The first report of Apiotrichum mycotoxinivorans isolation from human cerebrospinal fluid. Eur J Clin Microbiol Infect Dis 43, 597–604 (2024). https://doi.org/10.1007/s10096-023-04736-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-023-04736-0

Keywords

Navigation